Following advice from the IHR Emergency Committee, the Director-General of WHO declared yesterday that mpox is no longer a global health emergency. However, as with COVID-19, that does not mean that the work is over. Mpox continues to pose significant public health challenges that need a robust, proactive and sustainable response.
Other hot topics
152 million babies born preterm in the last decade
Preterm birth is now the leading cause of child deaths, accounting for more than 1 in 5 of all deaths of children occurring before their 5th birthday. Preterm survivors can face lifelong health consequences, with an increased likelihood of disability and developmental delays.
COVID-19 evolving variants
Why are we seeing rising number of COVID-19 cases in some parts of the world? How is the SARS-CoV-2 virus evolving? What do governments and the public need to do to live with COVID-19 safely? Dr Maria Van Kerkhove explains in Science in 5.
New WHO manual aims to strengthen pedestrian safety
Walking brings health, transport and environmental benefits, but roads remain unsafe for pedestrians everywhere. Pedestrians account for nearly a quarter of all road crash deaths, with the number of pedestrian victims rising at nearly twice the rate of all other road crash fatalities.
Seventy-sixth World Health Assembly
The Seventy-sixth World Health Assembly (WHA) is being held in Geneva, Switzerland, on 21–30 May 2023. WHA is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board.